COSTECH Integrated Repository

Immunohistochemical expression of BRCA1 and BRCA2 in a cohort of Ugandan men with prostate cancer: an analytical cross-sectional study

Show simple item record

dc.creator Amsi, Patrick T.
dc.creator Yahaya, James J.
dc.creator Kalungi, Sam
dc.creator Odida, Michael
dc.date 2021-05-27T07:05:25Z
dc.date 2021-05-27T07:05:25Z
dc.date 2020
dc.date.accessioned 2022-10-20T14:01:47Z
dc.date.available 2022-10-20T14:01:47Z
dc.identifier Amsi, P. T., Yahaya, J. J., Kalungi, S., & Odida, M. (2020). Immunohistochemical expression of BRCA1 and BRCA2 in a cohort of Ugandan men with prostate cancer: an analytical cross-sectional study. African Journal of Urology, 26(1), 1-9.
dc.identifier DOI: https://doi.org/10.1186/s12301-020-00079-w
dc.identifier http://hdl.handle.net/20.500.12661/3238
dc.identifier.uri http://hdl.handle.net/20.500.12661/3238
dc.description Full text article. Also available at https://doi.org/10.1186/s12301-020-00079-w
dc.description Mutation of the tumour suppressor genes BRCA1 and BRCA2 is thought to cause early development of prostate cancer which has poor prognosis. The purpose of this study was to determine the expression of BRCA1/2 and correlate it with clinicopathological factors for patients with prostate cancer in uganda. Retrospectively, we used immunohistochemistry to evaluate the expression of BRCA1/2 antibodies in tissue blocks of 188 patients with prostate cancer who were diagnosed between January 2005 and December 2014 in the Department of Pathology, Makerere College of Health Sciences. The Chi-Square test was used to determine the association of the categorical variables, whereas t-test was used to compare groups of mean of the variables in the study. Expression of BRCA1 and BRCA2 was found in 26.1% and 22.9% cases, respectively. Co-expression of BRCA1 and BRCA2 was found in only 7.4%. Gleason score was associated with expression of BRCA1 and BRCA2 (P = 0.013, P = 0.041, respectively). Age was not associated with BRCA1 and BRCA2 expression; P = 0.543, P = 0.091, respectively. Likewise, PSA was not associated with BRCA1 and BRCA2 expression; P = 0.446, P = 0.399, respectively. BRCA1 and BRCA2 proteins in this study were expressed more in cases with poorly differentiated prostate cancer than in cases with either well or moderately differentiated prostate cancer. Co-expression of BRCA1 and BRCA2 proteins in the same patient in our study was 3 times less than either BRCA1 or BRCA2 alone.
dc.language en
dc.publisher Springer Open
dc.subject Prostate cancer
dc.subject BRCA1
dc.subject BRCA2
dc.subject Immunohistochemistry
dc.subject Tumour suppressor genes
dc.subject Breast cancer
dc.subject Deoxynucleic acid
dc.subject DNA
dc.title Immunohistochemical expression of BRCA1 and BRCA2 in a cohort of Ugandan men with prostate cancer: an analytical cross-sectional study
dc.type Article


Files in this item

Files Size Format View
Patrick T. Amsi.pdf 1.212Mb application/pdf View/Open

This item appears in the following Collection(s)

Show simple item record

Search COSTECH


Advanced Search

Browse

My Account